Literature DB >> 31394320

Extended release of dexamethasone from oleogel based rods.

Russell Macoon1, Timothy Guerriero2, Anuj Chauhan3.   

Abstract

HYPOTHESIS: Topical and systemic methods are not able to deliver ophthalmic drugs for treatment of retinal diseases. Consequently, invasive monthly intravitreal injections through the eyeball are required to deliver retinal drugs. A reduction in the frequency of the injection through extended release of the drugs could have significant clinical benefits. EXPERIMENTS: Oleogels containing ethyl cellulose as the gelator at 10% (wt%) in soybean oil were loaded with dexamethasone above the solubility limit and expunged from a syringe to create cylindrical rods for extended drug delivery. The devices were imaged to explore particle distribution and drug release was measured under sink conditions in buffer. A model was developed and fitted to data to determine effective drug diffusivity.
FINDINGS: Dexamethasone is released slowly due to the presence of the drug particles that serve as drug depots. The release increases from 600 to 3000 h as the drug loading is increased from 3% to 28%. The release profiles can be modeled by considering drug dissolution and diffusion, as well as the tortuosity of the matrix due to the presence of the voids formed after the drug particles have dissolved. The proposed approach is promising as the release profiles of the drug are comparable to commercial devices.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Dexamethasone; Drug delivery; Modeling; Oleogel; Posterior segment

Mesh:

Substances:

Year:  2019        PMID: 31394320      PMCID: PMC6764860          DOI: 10.1016/j.jcis.2019.07.082

Source DB:  PubMed          Journal:  J Colloid Interface Sci        ISSN: 0021-9797            Impact factor:   8.128


  53 in total

Review 1.  Iontophoresis: a non-invasive ocular drug delivery.

Authors:  Esther Eljarrat-Binstock; Abraham J Domb
Journal:  J Control Release       Date:  2005-12-15       Impact factor: 9.776

Review 2.  Current and future ophthalmic drug delivery systems. A shift to the posterior segment.

Authors:  Eva M Del Amo; Arto Urtti
Journal:  Drug Discov Today       Date:  2008-01-08       Impact factor: 7.851

Review 3.  Inner blood-retinal barrier transporters: role of retinal drug delivery.

Authors:  Ken-ichi Hosoya; Masanori Tachikawa
Journal:  Pharm Res       Date:  2009-07-01       Impact factor: 4.200

4.  Evaluation of the physical stability of two oleogels.

Authors:  Isabel F Almeida; M Fernanda Bahia
Journal:  Int J Pharm       Date:  2006-07-25       Impact factor: 5.875

5.  Complications of sclera-covered enucleation implants.

Authors:  Philip L Custer; Sharon McCaffery
Journal:  Ophthalmic Plast Reconstr Surg       Date:  2006 Jul-Aug       Impact factor: 1.746

6.  Acute endophthalmitis following intravitreal triamcinolone acetonide injection.

Authors:  Darius M Moshfeghi; Peter K Kaiser; Ingrid U Scott; Jonathan E Sears; Matthew Benz; Juan P Sinesterra; Richard S Kaiser; Sophie J Bakri; Raj K Maturi; Jonathan Belmont; Paul M Beer; Timothy G Murray; Hugo Quiroz-Mercado; William F Mieler
Journal:  Am J Ophthalmol       Date:  2003-11       Impact factor: 5.258

7.  Characterisation of the thermal properties of ethylcellulose using differential scanning and quasi-isothermal calorimetric approaches.

Authors:  Hui Ling Lai; Kendal Pitt; Duncan Q M Craig
Journal:  Int J Pharm       Date:  2009-11-20       Impact factor: 5.875

8.  Safety of an intravitreal injection of triamcinolone: results from a randomized clinical trial.

Authors:  Mark C Gillies; Judy M Simpson; Frank A Billson; Wei Luo; Philip Penfold; William Chua; Paul Mitchell; Meidong Zhu; Alex B L Hunyor
Journal:  Arch Ophthalmol       Date:  2004-03

9.  A drug-eluting contact lens.

Authors:  Joseph B Ciolino; Todd R Hoare; Naomi G Iwata; Irmgard Behlau; Claes H Dohlman; Robert Langer; Daniel S Kohane
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-01-10       Impact factor: 4.799

10.  Cyclodextrin microparticles for drug delivery to the posterior segment of the eye: aqueous dexamethasone eye drops.

Authors:  Thorsteinn Loftsson; Dagný Hreinsdóttir; Einar Stefánsson
Journal:  J Pharm Pharmacol       Date:  2007-05       Impact factor: 3.765

View more
  2 in total

1.  In vitro release of hydrophobic drugs by oleogel rods with biocompatible gelators.

Authors:  Russell Macoon; Mackenzie Robey; Anuj Chauhan
Journal:  Eur J Pharm Sci       Date:  2020-06-12       Impact factor: 4.384

2.  Ophthalmic delivery of hydrophilic drugs through drug-loaded oleogels.

Authors:  Russell Macoon; Anuj Chauhan
Journal:  Eur J Pharm Sci       Date:  2020-11-01       Impact factor: 4.384

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.